14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.302 $0.440 Monday, 22nd Apr 2024 GLMD stock ended at $0.364. This is 2.33% less than the trading day before Friday, 19th Apr 2024. During the day the stock fluctuated 5.88% from a day low at $0.352 to a day high of $0.373.
90 days $0.300 $0.466
52 weeks $0.260 $5.63

Historical Galmed Pharmaceuticals Ltd. prices

Date Open High Low Close Volume
May 30, 2023 $4.61 $4.66 $4.30 $4.30 5 360
May 26, 2023 $4.70 $5.32 $4.60 $4.60 14 080
May 25, 2023 $5.24 $5.24 $5.10 $5.10 10 070
May 24, 2023 $5.14 $5.14 $4.65 $5.07 2 183
May 23, 2023 $4.99 $5.49 $4.90 $4.96 4 948
May 22, 2023 $4.93 $5.63 $4.93 $5.21 28 467
May 19, 2023 $4.57 $5.40 $4.44 $5.00 116 156
May 18, 2023 $4.90 $5.01 $4.44 $4.57 26 042
May 17, 2023 $4.50 $5.09 $4.07 $4.68 109 701
May 16, 2023 $4.13 $4.64 $3.75 $4.32 85 273
May 15, 2023 $4.50 $4.50 $3.43 $4.16 166 164
May 12, 2023 $0.325 $0.340 $0.320 $0.332 216 613
May 11, 2023 $0.350 $0.370 $0.340 $0.360 51 207
May 10, 2023 $0.380 $0.380 $0.357 $0.359 169 150
May 09, 2023 $0.380 $0.400 $0.361 $0.361 361 743
May 08, 2023 $0.351 $0.390 $0.341 $0.361 499 498
May 05, 2023 $0.390 $0.518 $0.358 $0.408 7 597 512
May 04, 2023 $0.310 $0.310 $0.291 $0.300 26 944
May 03, 2023 $0.320 $0.320 $0.301 $0.310 32 260
May 02, 2023 $0.300 $0.312 $0.295 $0.300 31 123
May 01, 2023 $0.309 $0.310 $0.290 $0.290 26 697
Apr 28, 2023 $0.300 $0.310 $0.300 $0.310 74 666
Apr 27, 2023 $0.320 $0.320 $0.300 $0.300 32 084
Apr 26, 2023 $0.320 $0.327 $0.300 $0.305 76 040
Apr 25, 2023 $0.330 $0.331 $0.306 $0.310 65 050
Click to get the best stock tips daily for free!

About Galmed Pharmaceuticals Ltd.

Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or type-II-diabetes mellitus. The company also evaluates Aramchol through ARRIVE Study, a Phase IIa clinica... GLMD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT